TAmiRNA to present multiomic advances at EUROTOX 2024 in Copenhagen

Vienna, Austria: Biotech and diagnostic innovator TAmiRNA will make its debut at the EUROTOX 2024 scientific meeting in Denmark, to highlight the importance of its small RNA sequencing platform for identifying diagnostic biomarkers.

TAmiRNA will be both a poster and presenter at the Copenhagen conference, which is focused on the newest aspects of modern toxicology and methodologies.

Multiomics revolution

As part of the EUROTOX Short Orals Session on Day Three (September 10, 1000-1200 hrs.), TAmiRNA CEO and Chief Scientific Officer Dr. Matthias Hackl will deliver a presentation on “Small RNA-sequencing based discovery of microRNAs for use as non-invasive biomarkers of CNS-injury”.

His presentation will highlight the valuable role of TAmiRNA’s recently developed miND® platform with spike-ins for developing a multiomics or panomics data analysis approach based on multiple -omes.

Dr. Hackl commented: “I aim to show how TAmiRNA has been successful in using to complex biological ‘big data’ to identify more rapidly novel associations between biological entities, pinpoint relevant biomarkers and build elaborate markers of disease and physiology to create a faster track bioinformatic pipeline.”

Next Generation Sequencing

TAmiRNA will also bring a poster (P06-01) to the conference, authored by Senior Scientist Dr. Kseniya Khamina-Kotisch. Again, as part of the overall topic of Omics in toxicology, the poster “NGS-based discovery of circulating microRNA biomarkers of drug-induced pancreatic injury (DIPI)” underlines the role of miND® spike-ins for NextGen small RNA-sequencing.

“We will also be active at this meeting in talking about our range of unique EV characterization services, such as transcriptomic analyses of both microRNAs and larger mRNAs or long non-coding RNA sequences, and their value to toxicologists working on biomarker diagnostic or therapeutic applications,” said Dr. Hackl.

About TAmiRNA

TAmiRNA specializes in technologies for profiling levels of blood-circulating miRNAs and developing multi-parametric classification algorithms (“signatures”). TAmiRNA uses these technologies to develop minimal-invasive diagnostic tests for drug development, early diagnosis, and prognosis of disease, and as companion diagnostic tests to support treatment decisions. Through its CRO business, TAmiRNA enables clients from academic to private sectors to perform high-quality.

TAmiRNA is among Europe´s first companies that have CE-marked a microRNA-based test – hepatomiR® – which is intended for the diagnosis of liver function in liver cancer patients.

For its work on circulating microRNAs in bone disease, TAmiRNA is receiving funding from the European Union’s Horizon 2020 research and innovation program under the MARIE SKŁODOWSKA-CURIE grant agreement no. 860898. For TAmiRNA´s work on novel drug safety biomarkers, TAmiRNA receives funding from the Innovative Medicines Initiative 2 Joint Undertaking “TransBioLine” under grant agreement No. 821283. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. For its work on senescence-associated biomarkers, TAmiRNA is receiving funding from Eureka-Eurostars grant Ab-SENS. For its work on novel liver function biomarkers, TAmiRNA is receiving funding from the Vienna Business Agency as well as FFG.

More information available at: www.tamirna.com

About EUROTOX 2024

EUROTOX is the Annual Congress of the European Societies of Toxicology and takes place each year in a different city of Europe. The meetings are dedicated to furthering interdisciplinary collaboration on toxicology within the medical industries and knowledge sharing on the newest aspects of modern toxicology and methodologies.

The 58^th Annual Congress, EUROTOX 2024, will be a four-day event, opening September 8 at Copenhagen’s striking Kim Utzon-designed Tivoli Congress Center at its waterside location in the center of the Danish capital.

The 2024 meeting is themed ‘Toxicology – A Quest for safe Chemicals and Medicines’, with a program stressing safety of drugs and environmental chemicals, new and emerging technologies, personalized medicine, human health effects caused by exposure to chemicals as well as safety issues arising from climate change.

The event is organized by the Danish Society of Toxicology & Pharmacology, with further information at: https://www.eurotox2024.com

Resources

Click on TAmiRNA EV characterization services to learn more.
Click on TAmiRNA miND® spike-ins for small RNA-sequencing for further information.